GSA Capital Partners LLP acquired a new position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,578 shares of the technology company’s stock, valued at approximately $899,000.
Other large investors also recently added to or reduced their stakes in the company. Quest Partners LLC boosted its position in shares of Plexus by 36,700.0% during the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock valued at $38,000 after acquiring an additional 367 shares during the last quarter. Innealta Capital LLC acquired a new position in Plexus in the 2nd quarter valued at about $51,000. Farther Finance Advisors LLC grew its stake in shares of Plexus by 89.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after buying an additional 219 shares during the period. EntryPoint Capital LLC increased its holdings in shares of Plexus by 56.2% during the 1st quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock worth $93,000 after buying an additional 351 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Plexus by 190.1% during the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after buying an additional 498 shares during the period. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Plexus Price Performance
PLXS opened at $153.13 on Friday. The stock’s 50-day moving average price is $139.43 and its 200 day moving average price is $122.29. Plexus Corp. has a 12-month low of $90.18 and a 12-month high of $169.41. The firm has a market cap of $4.17 billion, a price-to-earnings ratio of 38.19 and a beta of 0.87. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07.
Insiders Place Their Bets
In other Plexus news, CEO Todd P. Kelsey sold 2,000 shares of the stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $125.00, for a total value of $250,000.00. Following the sale, the chief executive officer now owns 85,026 shares of the company’s stock, valued at $10,628,250. This trade represents a 2.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael J. Running sold 579 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $153.93, for a total value of $89,125.47. Following the transaction, the insider now directly owns 1,569 shares of the company’s stock, valued at approximately $241,516.17. This represents a 26.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 35,552 shares of company stock worth $5,500,872 over the last 90 days. Corporate insiders own 2.39% of the company’s stock.
Analyst Ratings Changes
PLXS has been the subject of several recent analyst reports. StockNews.com cut Plexus from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. KeyCorp started coverage on Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Needham & Company LLC upped their target price on shares of Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research report on Friday, October 25th. Finally, Benchmark increased their target price on shares of Plexus from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Monday, October 28th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Plexus presently has a consensus rating of “Hold” and a consensus price target of $133.50.
Check Out Our Latest Stock Analysis on Plexus
Plexus Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories
- Five stocks we like better than Plexus
- Conference Calls and Individual Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Roth IRA Calculator: Calculate Your Potential Returns
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.